SCHEMBL17142008

SCHEMBL17142008

CC1(C)OB(c2ccc(-c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3ccccc3-4)c3ccccc23)OC1(C)C

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.38
LIPG Q9Y5X9 5/20 0.38
PDK2 Q15119 8/20 0.34
PRMT5 O14744 1/20 0.30
WDR77 Q9BQA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29738313 0.90 LPL (0.38) LPLLIPGPDK2PRMT5WDR77
SCHEMBL12442308 0.90 LPL (0.38) LPLLIPGPDK2PRMT5WDR77
SCHEMBL12781906 0.88 LPL (0.41) LPLLIPGPDK2
SCHEMBL17142003 0.86 LPL (0.37) LPLLIPGPDK2
SCHEMBL21995601 0.86 LPL (0.37) LPLLIPGPDK2
SCHEMBL31050384 0.83 PGR (0.34) LPLLIPGPDK2
SCHEMBL26179604 0.83 LPL (0.35) LPLLIPG
SCHEMBL12781885 0.82 LIPG (0.46) LPLLIPGPRMT5WDR77
SCHEMBL12791300 0.82 LIPG (0.42) LPLLIPGPRMT5WDR77
SCHEMBL29637486 0.82 LIPG (0.42) LPLLIPGPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381572-B2 Heterocyclic compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2019-08-13 US disclosed
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-04-11 US disclosed
WO-2017157983-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2017-09-21 WO disclosed
US-20170018718-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-01-19 US disclosed
WO-2015152651-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2015-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES TEC, NUDT1, DPYD LPL 4755/4885LIPG 4611/4885PDK2 157/4885
US-10381572-B2 Heterocyclic compound and organic light-emitting element comprising same CRY1, CRY2, PER2 LPL 2062/4885LIPG 2731/4885PDK2 2847/4885
US-20170018718-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 LPL 2062/4885LIPG 2731/4885PDK2 2847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.